ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36535
0.00%
Bitcoin
67,552.08
0.10%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Oyster Point Pharma Inc (OYST)

  7. Oyster Point Pharma Inc (OYST) News

OYST

Oyster Point Pharma (OYST)

Oyster Point Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OYST
DateTimeSourceHeadlineSymbolCompany
02/14/20233:34PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OYSTOyster Point Pharma Inc
02/14/20239:06AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OYSTOyster Point Pharma Inc
01/13/20234:11PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:OYSTOyster Point Pharma Inc
01/13/20234:06PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OYSTOyster Point Pharma Inc
01/06/20235:04AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OYSTOyster Point Pharma Inc
01/05/20233:33PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OYSTOyster Point Pharma Inc
01/05/20233:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
01/04/20235:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
01/04/20234:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
01/04/20234:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
01/04/20234:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
01/04/20234:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
01/04/20234:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
01/04/20234:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
01/03/20238:53AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:OYSTOyster Point Pharma Inc
01/03/20238:26AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OYSTOyster Point Pharma Inc
01/03/20238:19AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:OYSTOyster Point Pharma Inc
01/03/20238:07AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OYSTOyster Point Pharma Inc
12/23/20225:31AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OYSTOyster Point Pharma Inc
12/22/20224:16PMEdgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OYSTOyster Point Pharma Inc
12/21/20225:04AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OYSTOyster Point Pharma Inc
12/09/20226:01AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OYSTOyster Point Pharma Inc
12/09/20226:01AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OYSTOyster Point Pharma Inc
12/06/20227:51AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
12/05/20224:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
12/02/20227:00AMGlobeNewswire Inc.Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OYSTOyster Point Pharma Inc
12/01/20226:39AMEdgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OYSTOyster Point Pharma Inc
12/01/20225:12AMEdgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:OYSTOyster Point Pharma Inc
11/16/20223:25PMEdgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OYSTOyster Point Pharma Inc
11/14/20227:10AMEdgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:OYSTOyster Point Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:OYST

Your Recent History

BIT
UB8R00
Unicredit Bank
COIN
CRAFTTUST
CRAFT
NASDAQ
BLMN
Bloomin Brands
COIN
WBCUST
Weber
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved